ChidiANwizuMD
Infectious Disease • Baltimore, MDAssistant Professor, Medicine, University of Maryland School of Medicine
Are you Dr. Nwizu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 23 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-706-4613Fax+1 410-706-4619- Is this information wrong?
Summary
- Dr. Chidi Nwizu, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland, North Carolina, and Vermont. He is affiliated with Portland HCS and is an Assistant Professor at University of Maryland School of Medicine.
Education & Training
Harlem Hospital CenterResidency, Internal Medicine, 1995 - 1998
University of Benin Faculty of MedicineClass of 1988
Certifications & Licensure
OR State Medical License 2014 - 2025
NC State Medical License 2022 - 2025
VT State Medical License 2016 - 2024
MS State Medical License 1999 - 2024
GA State Medical License 2013 - 2017
MD State Medical License 2008 - 2015
UT State Medical License 2006 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Join now to see all
Publications & Presentations
PubMed
- HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial.Cassidy W. Claassen, David Keckich, Chidi Nwizu, Alash'le Abimiku, Donald Salami, Michael Obiefune, Bruce L. Gilliam, Anthony Amoroso> ;Journal of the International Association of Providers of AIDS Care. 2019 Jan 29
- 3 citationsPain Management for Persons Living With HIV Disease: Experience With Interprofessional Education in Nigeria.Carla Alexander, Gregory Pappas, Yvonne Henley, Angela Kaiza Kangalawe, Folaju O Oyebola, Michael Obiefune, Ejike Nwene, Winifred Stanis-Ezeobi, Victor Enejoh, Chidi N...> ;The American Journal of Hospice & Palliative Care. 2015 Aug 1
- 19 citationsRaltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of...Janaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, Cecilia L Moore, Marcello H Losso, Chidi A Nwizu, Lerato Mohapi, Stephen J Kerr, Annette H Sohn, Hedy Teppler, Bo...> ;Plos One. 2015 Jan 1
- Join now to see all
Hospital Affiliations
Portland HCSPortland, Oregon
